Perceptual Learning Approaches for Cognitive Impairment
Trial Summary
What is the purpose of this trial?
This is a research study about how training can impact performance on cognitive tasks. Participants are between 18 and 30 and 60 to 85 years of age, have normal (or corrected to normal) vision, and have no neurological conditions that would preclude their ability to complete computerized cognitive tasks. Up to 1140 participants will be on study for up to 8 weeks.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Perceptual Learning Approaches for Cognitive Impairment?
Research shows that cognitive training can improve attention and processing speed in older adults, and auditory training enhances the perception of complex sounds and speech. These findings suggest that perceptual learning approaches, which include attention and auditory training, may help improve cognitive function in individuals with cognitive impairment.12345
Is perceptual learning safe for humans?
How does the treatment 'Perceptual Learning Approaches for Cognitive Impairment' differ from other treatments for cognitive impairment?
This treatment is unique because it uses perceptual learning, which involves training the brain to improve sensory and attentional functions through repeated practice. Unlike traditional drug treatments, it leverages the brain's plasticity to enhance cognitive abilities, making it a non-invasive option that can be tailored to individual needs.311121314
Research Team
C. Shawn Green
Principal Investigator
University of Wisconsin, Madison
Eligibility Criteria
This trial is for individuals between 18 and 30 years old with corrected vision of at least 20/40. They should not have any history of retinal pathology or neurological disease.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo perceptual learning tasks across 12 separate conditions to assess the effects of training on cognitive and perceptual performance.
Crossover Training
Younger cohort participants undergo a crossover design to train on two tasks sequentially to examine learning and generalization.
Follow-up
Participants are monitored for safety and effectiveness after training, with assessments on transfer to visual search, auditory attention, and reading.
Treatment Details
Interventions
- Complex Features (CF)
- Endogenous Attention Training (EnAT)
- Exogenous Attention Training (ExAT)
- Long Training (LT)
- Mixed Difficulty (MD)
- Multisensory Facilitation (MF)
- No Contact Control
- Noise Training (NT)
- Parafoveal Training (PT)
- Short Staircases (SS)
- Standard Perceptual Learning (SPL)
- Stimulus Variety (SV)
- Training with Flankers (TWF)
Complex Features (CF) is already approved in European Union, United States for the following indications:
- Breast cancer
- Ovarian cancer
- Fallopian tube cancer
- Peritoneal cancer
- Pancreatic cancer
- Prostate cancer
- Endometrial cancer
- Ovarian, fallopian tube, and primary peritoneal cancer
- Breast cancer
- Prostate cancer
- Pancreatic cancer
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Eye Institute (NEI)
Collaborator